დასაწყისი · კატალოგი · პროფილი · ცხრილი
სკრინინგი BODY HANDBOOK
სკრინინგი · §108
Colorectal Cancer Screening
Colorectal cancer is one of the very few common cancers you can prevent rather than just detect early — most cases grow from a benign polyp over ten to fifteen years, and the polyp can be cut out before it ever turns malignant. The catch: you have to actually look. Three modalities have evidence behind them in the US — a colonoscopy every ten years, a fecal immunochemical test (FIT) every year, or a multi-target stool DNA test (Cologuard) every one to three years — and the right one is whichever you'll actually finish. Start at 45, run until 75, and treat 76–85 as a conversation with your doctor.
გააკეთე · ყოველწლიურად მტკიცებულება ძლიერი თავი სკრინინგი

The longevity case is the entire pitch — by the population math, a 45-year-old who stays on schedule cuts their lifetime risk of dying from colon cancer by roughly three-quarters. Everything else is cheap: in the US the law makes it free if you're insured, the home test takes ten minutes once a year, the colonoscopy is one bad day every ten. The argument among specialists is which test, not whether to test. The thing most likely to fail isn't the test — it's never doing it.

Almost every colorectal cancer starts as a small lump of overgrown lining called a polyp. Most polyps never become cancer, but the ones that do take roughly ten to fifteen years to make the trip. That long, slow window is the whole reason screening works: there is a thing to find, and finding it early means either cutting it out before it becomes cancer, or catching the cancer when it's still curable. Stage I colon cancer has a five-year survival around 91%; stage IV is around 14% Siegel 2024.

The three recommended tests work two different ways. A colonoscopy is direct visual inspection — a flexible camera the length of your large intestine, with tools to snip out polyps in the same session. It's both detection and prevention in one procedure. The two home tests look for what cancer and large polyps leak into stool: FIT uses antibodies that bind to blood, and multi-target stool DNA (the one called Cologuard) adds genetic mutations and altered DNA methylation patterns that tumors shed Imperiale 2014. The home tests are pure detection. If they flag anything, you still need a colonoscopy to look and remove.

Does it actually work

Direct, randomized proof that screening lowers your odds of dying from colorectal cancer is strongest for the camera tests. A British trial of 170,000 adults given a single look at the lower colon at age 55–64 saw colorectal cancer deaths drop 31% over the following decade Atkin 2010. The US PLCO trial, with a longer follow-up, found a 25% mortality drop Schoen 2018. The home stool tests have their own evidence — earlier-generation blood-based stool tests cut colorectal cancer death by about 12% in pooled randomized trials, and the newer FIT and DNA versions perform better in head-to-head accuracy studies than the old guaiac cards they replaced Lin 2021.

The closest thing to a settled answer comes from the modeling work the USPSTF commissioned. Across roughly two dozen simulated screening strategies, colonoscopy every ten years, annual FIT, and three-yearly stool DNA all land in the same neighbourhood: 22 to 25 colorectal cancer deaths prevented for every 1,000 people who actually screen from 45 to 75, with very similar life-years gained Knudsen 2021. The differences between modalities are small. The difference between any modality and no screening is large.

What it looks like if you skip it

About one in 25 Americans will be diagnosed with colorectal cancer at some point SEER 2024. The trajectory for most of those people if no one screens them: a small polyp at 45, a larger polyp at 52, a cancer at 58, blood in the stool or unexplained fatigue at 60, a diagnosis at stage III. The cancer that was a five-minute outpatient snip at 50 is now a colectomy, six months of chemotherapy, a temporary colostomy bag for some, a permanent one for a few. The five-year survival numbers you see published are the average across stages — the people you actually know who died of colon cancer were usually diagnosed late.

The under-50 cohort is the other half of this. Colorectal cancer in people in their thirties and forties has been climbing roughly 3% a year for two decades, and nobody knows exactly why — the leading suspects are diet, the microbiome, antibiotic exposure in childhood, but the science isn't settled Wolf 2018. That rise is the reason the start age dropped from 50 to 45 in 2021. If your parent, sibling, or child had colon cancer, your number isn't 45 — it's 40, or ten years before whichever relative was diagnosed, whichever is earlier.

What to actually do

The official menu is wider than the popular version. The US Preventive Services Task Force grade-B recommendation, which is what makes screening free under your insurance, lists three first-line modalities USPSTF 2021. Pick one. Stay on its interval. Get a follow-up colonoscopy if a stool test comes back positive.

If a colonoscopy finds polyps, the next interval shortens. One or two small (under 10 mm) tubular adenomas pushes the next exam to 7–10 years. Three or more, or any with high-grade dysplasia or large serrated lesions, pushes it to 3 years Gupta 2020. These shorter intervals are surveillance, not screening, but they are how a real screening program actually runs in the long term.

Colonoscopy or stool test — which one

The honest answer: the one you'll actually do. The modeling work that underpins the USPSTF guideline finds the three first-line strategies almost interchangeable in lifetime mortality reduction when followed on schedule Knudsen 2021. The wrong answer is whichever one you keep planning to schedule and never do.

That said, the tradeoffs are real:

  • Colonoscopy is the only single-step test — the camera both finds and removes polyps in the same session. If you have a positive family history, a long gap since your last screen, or you'd rather get it over with for a decade, this is the high-information choice. The price is one miserable day of bowel prep, sedation, and a recovery day, plus a roughly 1-in-1,000 chance of a serious complication like a perforation or bleed Reumkens 2016.
  • FIT is the simplest and cheapest test. A small stool sample, mailed to a lab, repeated every year. The downside is annual repetition and the fact that if it comes back positive — about 5% of the time — you're going to colonoscopy anyway.
  • Multi-target stool DNA (Cologuard) catches more polyps than FIT but flags more false positives — about 13% of users get a positive that turns into a normal colonoscopy Imperiale 2014. The interval is 1–3 years; insurance and Medicare reimburse at 3.

Europe screens most of its population with FIT-first and uses colonoscopy only for follow-up. The US does both. The math says either approach gets you most of the way there.

What people get wrong

"The 2022 colonoscopy trial proved colonoscopy doesn't work." No. NordICC invited people; 58% never showed up. The mortality-reduction estimate among the people who actually got the colonoscopy was about 50%, in line with everything observational evidence had suggested Bretthauer 2022. What the trial really showed is that a screening program is only as good as its uptake.

"The home test is just as good as the colonoscopy." For finding cancer, almost — Cologuard catches 92% of cancers, colonoscopy around 95% Imperiale 2014. For finding the precancerous polyps you actually want to remove before they become cancer, the gap is wide: colonoscopy sees and removes them in one go; the stool DNA test catches about 43% of advanced polyps and Cologuard can't remove anything.

"I'm under 50, so I'm fine." The start age dropped to 45 in 2021, and colon cancer in your 30s and 40s has been rising for two decades USPSTF 2021. Symptoms — rectal bleeding, persistent change in bowel habits, unexplained weight loss, iron deficiency with no obvious cause — get worked up at any age, not waved off as hemorrhoids or stress; unexplained iron loss in an adult is a reason to get scoped, not just to take iron.

"A clean colonoscopy means I'm safe for 10 years." Mostly. But cancers that grow in the gap — "interval cancers" — happen, especially from polyps the endoscopist missed. Adenoma detection rates vary widely; the quality of the endoscopist matters. If you can choose, pick a gastroenterologist whose center publishes its detection rate and reports it above 30%.

Where it goes wrong

Colonoscopy has small but real direct harms. Across population screening programs, perforation happens at roughly half to one in 1,000 procedures, and bleeding after polyp removal at around two in 1,000; both rates roughly double after 65 and roughly triple if any polyps get removed Reumkens 2016. Sedation can drop blood pressure or breathing in someone with serious cardiac or lung disease. The bowel prep can cause electrolyte trouble in people with kidney disease.

The failure modes that matter at a population level:

  • Never screened. About 28% of eligible US adults aren't up to date. This is the largest source of preventable colorectal cancer death in the country. It's not a screening problem; it's an access problem.
  • Positive stool test, no follow-up. The home test only works if a positive becomes a colonoscopy. Without it, you've just paid for an alarm you ignored.
  • Missed polyps. Even a good colonoscopist misses some lesions, especially flat ones in the right colon. Adenoma detection rate is the closest thing to a quality metric — every 1% higher detection rate maps to about 3% fewer interval cancers in the years after.
  • Skipping the prep. An incompletely cleaned colon is the most common reason a colonoscopy gets reported as "limited" — and limited means you may need to redo it sooner.

What it costs and how to get it done

In the US, if you have health insurance, this is free. The Affordable Care Act requires insurers and Medicare to cover any USPSTF grade-A or grade-B preventive screen with no copay, no deductible, no coinsurance, in network. As of 2022, federal rules also cleared up the old loophole where a colonoscopy after a positive home test got billed as diagnostic — that follow-up colonoscopy is now screening too, also free.

Out of pocket: a colonoscopy retails $1,500–$5,000 depending on the facility; FIT kits run $20–$50; Cologuard runs $500–$700. Time costs: a stool test takes ten minutes once a year — you collect a sample at home, drop it in the mail. A colonoscopy takes one bad day and one recovery day. The day before is a clear-liquid diet and a bowel prep — typically a few liters of laxative solution split between evening and early morning. The procedure itself is 30–60 minutes under sedation; you need a ride home and shouldn't drive or work the rest of the day.

If you've been putting it off because the prep sounds terrible: it is, but it's one day every ten years, and the newer split-dose preps are considerably more tolerable than the old gallon-at-once versions.

Higher-risk groups: different rules

The 45-and-stool-test menu is for average risk. If any of the following apply, you're not in that category and need a colonoscopy-based plan from a gastroenterologist Patel 2022:

  • Family history. A first-degree relative (parent, sibling, child) diagnosed with colorectal cancer or an advanced polyp. Start at 40, or 10 years before that relative's age at diagnosis, whichever is earlier. Repeat every 5 years rather than 10. Stool tests are not validated in this group.
  • Lynch syndrome (hereditary nonpolyposis colorectal cancer) — the inherited cause a genetic panel can flag. Colonoscopy every 1–2 years starting at 20–25.
  • Familial adenomatous polyposis (FAP). Annual colonoscopy or sigmoidoscopy starting from puberty; many patients eventually have the colon removed.
  • Inflammatory bowel disease (ulcerative colitis or Crohn's colitis, when the colon has been inflamed for 8 or more years). Surveillance colonoscopy every 1–2 years, often with extensive biopsies.
  • Prior colorectal cancer or advanced adenoma. You're in surveillance, not screening, and your gastroenterologist sets the interval.

Black Americans carry higher colorectal cancer incidence and the highest mortality of any US racial group, with more cancers in the upper colon where stool tests are less sensitive Siegel 2024. The 45 start age applies universally now, but the case for colonoscopy as the test of choice is stronger.

What you get from staying on schedule

The honest payoff is most of it invisible. Most people who screen on schedule from 45 to 75 never know the screening did anything — they get clean results, repeat in a decade, and never develop colon cancer. That's the success case. It looks identical, in your day-to-day, to having skipped the whole thing. The difference is what doesn't happen: the diagnosis at 60, the surgery, the chemotherapy, the conversation with your kids about how long you have.

For the ~10% of people who turn out to have a polyp on their first scope, the payoff is concrete and immediate — the gastroenterologist snips it out during the same procedure, sends it to pathology, and what would have been a cancer in eight years no longer exists. The follow-up interval shortens, but the cancer doesn't happen. For the small number who have a cancer found early, the payoff is the difference between stage I and stage III. Stage I colon cancer — surgery, no chemotherapy, 5-year survival above 90% Siegel 2024. Stage III — surgery plus six months of chemo, survival in the 70s. Stage IV — survival in the teens.

At the population level, the modeling estimate is that a 45-year-old who actually completes screening through 75 cuts their lifetime risk of dying from colorectal cancer by roughly three-quarters Knudsen 2021. The decade you don't notice is the payoff.

Two other testing modalities are USPSTF-approved but used less in practice: CT colonography (a low-radiation CT scan, every 5 years) and flexible sigmoidoscopy (a shorter camera that sees only the lower colon). Both are options when standard colonoscopy isn't feasible. Blood-based screening tests for circulating tumor DNA are newer and easier to complete than stool tests, but currently catch fewer cancers and far fewer polyps; whether they'll change the screening landscape is an active question. And screening sits inside a broader colorectal cancer picture — diet, fiber, alcohol, body weight, physical activity, and smoking all move the underlying risk you're screening against.

დაკავშირებული სახელმძღვანელოში
დიაგნოზი
  • — Unexplained iron loss in an adult can mean a slow bleed from the colon. It's a reason to get scoped, not just take iron.
დაკავშირებული
  • — Colorectal screening is one line on the adult schedule — start at 45 and run to 75.
  • — If a gene panel shows Lynch syndrome, colon screening starts earlier and runs tighter — it cuts colon-cancer death by two-thirds.
  • — Like cervical screening, this catches the disease at a precancerous stage — the win is in actually going.
  • — One slow driver of colon cancer is a thinned gut mucus layer from a fibre-poor diet; screening catches what that inflammation starts.
  • — Bleeding, weight loss, and night symptoms are also IBD red flags, not just cancer signs — both deserve a proper look.
  • — Colonoscopy or stool testing is a proven screen with real mortality benefit — don't let a multi-cancer blood test crowd it out.
  • — Diet, including resistant starch, nudges colon-cancer risk, but it doesn't replace getting scoped at the recommended age.
  • — Feeding the bacteria that make butyrate lowers colon-cancer odds, but the scope is still what actually catches it early.
·
108